Susquehanna International Group
GNCA

Susquehanna International Group’s Genocea Biosciences, Inc. GNCA Stock Holding History

Susquehanna International Group’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-56,458
Closed -$129K – 12155
2020
Q3 		$129K Sell
56,458
-4,324
-7% -$11.3K ﹤0.01% 9788
2020
Q2 		$140K Sell
60,782
-3,526
-5% -$8.12K ﹤0.01% 9309
2020
Q1 		$111K Buy
+64,308
New +$130K ﹤0.01% 9252
2019
Q4 		– Sell
-42,354
Closed -$100K – 11262
2019
Q3 		$123K Buy
42,354
+24,932
+143% +$85.1K ﹤0.01% 9448
2019
Q2 		$68K Buy
17,422
+15,347
+740% +$80.1K ﹤0.01% 9758
2019
Q1 		$10K Buy
+2,075
New +$10.3K ﹤0.01% 8659
2018
Q2 		– Sell
-5,602
Closed -$47K – 10855
2018
Q1 		$47K Buy
5,602
+2,905
+108% +$24.1K ﹤0.01% 8973
2017
Q4 		$25K Sell
2,697
-2,833
-51% -$28.5K ﹤0.01% 9047
2017
Q3 		$65K Buy
+5,530
New +$210K ﹤0.01% 8486
2017
Q2 		– Sell
-5,557
Closed -$271K – 10202
2017
Q1 		$271K Buy
5,557
+3,149
+131% +$123K ﹤0.01% 7507
2016
Q4 		$79K Buy
+2,408
New +$79.3K ﹤0.01% 9171
2016
Q3 		– Sell
-6,503
Closed -$213K – 9382
2016
Q2 		$213K Buy
+6,503
New +$238K ﹤0.01% 7514

Other funds holding GNCA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Susquehanna International Group's GNCA Position: Q4 2020 in Review

Susquehanna International Group sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2020, closing a stake of 56,458 shares — an estimated $129K sold.

Susquehanna International Group first reported a position in GNCA in Q2 2016 and held it in 12 quarters. The position peaked at $271K in Q1 2017. 39 funds tracked by Wall St. Rank hold GNCA as of Q4 2020.

  • Susquehanna International Group reported no remaining Genocea Biosciences, Inc. position as of Q4 2020 after selling out during the quarter.
  • Susquehanna International Group sold 56,458 Genocea Biosciences, Inc. shares in Q4 2020, an estimated $129K.
  • Susquehanna International Group first reported a position in Genocea Biosciences, Inc. in Q2 2016 and held it in 12 quarters.
  • Susquehanna International Group's Genocea Biosciences, Inc. position peaked at $271K in Q1 2017.
  • 39 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2020.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.